TABLE 2.
Clinical characteristics | Value |
P valuea | |
---|---|---|---|
Children with varicella (n = 106) | Controls (n = 106) | ||
Age (yr) | |||
Mean ± SD | 5.2 ± 2.9 | 5.2 ± 3.0 | |
Median | 4 | 4 | |
Range | 1–13 | 1–14 | |
No. (%) of females | 50 (47.2) | 50 (47.2) | |
No. (%) who received varicella vaccine | 100 (94.3) | 103 (97.2) | 0.3173 |
No. (%) with varicella vaccination before 12 months of age | 0 (0.0) | 1 (1.2) | 0.4885 |
No. (%) with varicella vaccination before 15 months of age | 75 (84.3) | 76 (90.5) | 0.2585 |
Mean ± SD age at varicella vaccination (mo)b | 14.9 ± 9.2 | 13.3 ± 4.2 | 0.1403 |
No. (%) who received varicella vaccine within 28 days of MMR vaccinec | 15 (21.7) | 41 (58.5) | <.0001 |
P values were obtained by McNemar's test except age at varicella vaccination, which was obtained by a paired t test.
The date of varicella vaccination was obtained in 89 children in the varicella group and 84 children in the control group.
Duration from MMR vaccination to varicella vaccination was obtained in 69 children in the varicella group and 70 children in the control group.